World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 91 11763 11066 6031 5583 564 30060

Edward M. Messing publications per year

The chart shows the history of publications by Edward M. Messing between 1976 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Edward M. Messing published across 51 years, from 1976 to 2026, averaging 12.4 papers a year. Output peaked at 35 publications in 2017. 23 of the 630 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1976 to 2026. Vertical axis: number of publications, 0 to 35. Peak 35 publications in 2017. 1976: 2 publications 1977: 0 publications 1978: 2 publications 1979: 2 publications 1980: 0 publications 1981: 2 publications 1982: 1 publication 1983: 0 publications 1984: 3 publications 1985: 4 publications 1986: 4 publications 1987: 9 publications 1988: 2 publications 1989: 3 publications 1990: 5 publications 1991: 3 publications 1992: 8 publications 1993: 4 publications 1994: 7 publications 1995: 9 publications 1996: 9 publications 1997: 6 publications 1998: 6 publications 1999: 8 publications 2000: 6 publications 2001: 11 publications 2002: 12 publications 2003: 13 publications 2004: 18 publications 2005: 26 publications 2006: 27 publications 2007: 18 publications 2008: 22 publications 2009: 17 publications 2010: 14 publications 2011: 13 publications 2012: 30 publications 2013: 22 publications 2014: 29 publications 2015: 22 publications 2016: 25 publications 2017: 35 publications 2018: 22 publications 2019: 20 publications 2020: 20 publications 2021: 25 publications 2022: 15 publications 2023: 34 publications 2024: 12 publications 2025: 21 publications 2026: 2 publications
1976 2026

630 publications in total across all disciplines

View publications per year as a table
Edward M. Messing: publications per year, 1976 to 2026
Year Publications
1976 2
1977 0
1978 2
1979 2
1980 0
1981 2
1982 1
1983 0
1984 3
1985 4
1986 4
1987 9
1988 2
1989 3
1990 5
1991 3
1992 8
1993 4
1994 7
1995 9
1996 9
1997 6
1998 6
1999 8
2000 6
2001 11
2002 12
2003 13
2004 18
2005 26
2006 27
2007 18
2008 22
2009 17
2010 14
2011 13
2012 30
2013 22
2014 29
2015 22
2016 25
2017 35
2018 22
2019 20
2020 20
2021 25
2022 15
2023 34
2024 12
2025 21
2026 2
Total 630
Download as CSV

Edward M. Messing publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Edward M. Messing sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 561–580 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 564 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504 564
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Edward M. Messing D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Edward M. Messing sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 90–91 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922 91
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Edward M. Messing is affiliated with the University of Rochester Medical Center in the United States. Their research primarily focuses on the medical field, with a significant concentration on surgery and pulmonary and respiratory medicine. Additional subfields of study include molecular biology, oncology, and urology.

The scientist's work extensively covers topics related to bladder and urothelial cancer treatments, urinary and genital oncology studies, and prostate cancer research, both in treatment and diagnosis. Renal cell carcinoma treatment, esophageal cancer research and treatment, and extracellular vesicles in disease are also among the key areas of study.

Frequent coauthors include Jean Joseph, Shuyuan Yeh, Yi-Fen Lee, Chawnshang Chang, and Christopher Silvers. These collaborations have contributed to a range of publications and research developments within the fields of urology and oncology.

Edward M. Messing publishes regularly in a selection of journals, with the most frequent venues being The Journal of Urology, Bladder Cancer, Urologic Oncology Seminars and Original Investigations, Urology Practice, and European Urology.

Notable recent papers include:

  • "Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma" (2021) published in European Urology
  • "The androgen receptor in bladder cancer" (2023) published in Nature Reviews Urology
  • "Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study" (2023) published in The Journal of Urology
  • "Tenascin-C expression in the lymph node pre-metastatic niche in muscle-invasive bladder cancer" (2021) published in British Journal of Cancer
  • "Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members" (2020) published in Urologic Oncology Seminars and Original Investigations

Best Publications

  • Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.

    E M Messing;J Manola;M Sarosdy;G Wilding

  • Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

    Ian M. Thompson;Catherine M. Tangen;Jorge Paradelo;M. Scott Lucia

  • Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy

    Edward M Messing;Judith Manola;Jorge Yao;Maureen Kiernan

  • Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.

    Ian M. Thompson;Catherine M. Tangen;Jorge Paradelo;M. Scott Lucia

  • Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904.

    Emil Scosyrev;Edward M. Messing;Richard Sylvester;Steven Campbell

  • Interstitial cystitis: early diagnosis, pathology, and treatment.

    Edward M. Messing;Thomas A. Stamey

  • Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline

    Rodney Davis;J. Stephen Jones;Daniel A. Barocas;Erik P. Castle

  • Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

    Vinata B. Lokeshwar;Tomonori Habuchi;H. Barton Grossman;William M. Murphy

  • Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment

    Mark S. Soloway;Joseph V. Briggman;Gennaro A. Carpinito;Gerald W. Chodak

  • Promotion of Bladder Cancer Development and Progression by Androgen Receptor Signals

    Hiroshi Miyamoto;Zhiming Yang;Yei Tsung Chen;Hitoshi Ishiguro

  • Detection of bladder cancer using a point-of-care proteomic assay.

    H. Barton Grossman;Edward Messing;Mark Soloway;Kevin Tomera

  • Androgen deprivation therapy for prostate cancer: current status and future prospects.

    Hiroshi Miyamoto;Edward M. Messing;Chawnshang Chang;Chawnshang Chang

  • Phase III Study of Interferon Alfa-NL as Adjuvant Treatment for Resectable Renal Cell Carcinoma: An Eastern Cooperative Oncology Group/Intergroup Trial

    Edward M. Messing;Judith Manola;George Wilding;Kathleen Propert

  • Sex and racial differences in bladder cancer presentation and mortality in the US

    Emil Scosyrev;Katia Noyes;Changyong Feng;Edward Messing

  • A Pilot Clinical Trial of Oral Pentosan Polysulfate And Oral Hydroxyzine in Patients With Interstitial Cystitis

    G.R. Sant;K.J. Propert;P.M. Hanno;D. Burks

  • Androgen receptor is a tumor suppressor and proliferator in prostate cancer

    Yuanjie Niu;Saleh Altuwaijri;Kuo-Pao Lai;Chun-Te Wu

  • Predominant Treatment Failure in Postprostatectomy Patients Is Local: Analysis of Patterns of Treatment Failure in SWOG 8794

    Gregory P. Swanson;Michael A. Hussey;Catherine M. Tangen;Joseph Chin

  • Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations.

    Edward M. Messing;Edward M. Messing;Theresa B. Young;Vernon B. Hunt;Kennedy W. Gilchrist

  • Surveillance for recurrent bladder cancer using a point-of-care proteomic assay.

    H. Barton Grossman;Mark Soloway;Edward Messing;Giora Katz

  • Is there a favorable subset of patients with prostate cancer who develop oligometastases

    Deepinder Singh;Won Sam Yi;Ralph A Brasacchio;Ann G Muhs

Frequent Co-Authors

Chawnshang Chang
Chawnshang Chang University of Rochester Medical Center
Shuyuan Yeh
Shuyuan Yeh University of Rochester Medical Center
Supriya G. Mohile
Supriya G. Mohile University of Rochester Medical Center
Ian M. Thompson
Ian M. Thompson The University of Texas Health Science Center at San Antonio
Catherine M. Tangen
Catherine M. Tangen Fred Hutchinson Cancer Research Center
George Wilding
George Wilding University of Wisconsin–Madison
H. Barton Grossman
H. Barton Grossman The University of Texas MD Anderson Cancer Center
Yair Lotan
Yair Lotan The University of Texas Southwestern Medical Center
E. David Crawford
E. David Crawford University of California, San Diego
Donald L. Trump
Donald L. Trump University of Virginia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to a medical career in the USA is diverse, with several related degrees and pathways available online. Many students interested in healthcare leadership can consider cahme-accredited online mha programs, which prepare graduates for management roles in hospitals and other clinical settings.

Registered Nurses looking to upskill can explore flexible options like the rn to bsn without clinicals pathway. This allows working RNs to advance their education without the need for additional in-person clinical hours, making it accessible for busy professionals.

For those aiming for advanced clinical or academic positions, the shortest dnp programs offer a fast track to a Doctor of Nursing Practice degree. These programs are designed for efficiency while maintaining academic rigor.

Affordability remains a concern for many students; fortunately, some of the cheapest dnp program options can help reduce the financial burden of advanced nursing education, making career progression possible for a wider range of students.

Best Scientists Citing Edward M. Messing

Trending Scientists

Recently Published Articles